Thematics Asset Management Acquires 7,000 Shares of Danaher Corporation $DHR

Thematics Asset Management boosted its holdings in shares of Danaher Corporation (NYSE:DHRFree Report) by 8.3% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 91,702 shares of the conglomerate’s stock after buying an additional 7,000 shares during the quarter. Thematics Asset Management’s holdings in Danaher were worth $18,181,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. WFA of San Diego LLC bought a new stake in shares of Danaher during the 2nd quarter worth about $26,000. Howard Hughes Medical Institute bought a new position in shares of Danaher in the 2nd quarter valued at approximately $27,000. ANTIPODES PARTNERS Ltd acquired a new stake in Danaher in the 3rd quarter worth approximately $27,000. TruNorth Capital Management LLC acquired a new stake in Danaher in the 3rd quarter worth approximately $28,000. Finally, Tripletail Wealth Management LLC bought a new stake in Danaher during the third quarter worth approximately $31,000. 79.05% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts have recently commented on DHR shares. Jefferies Financial Group lifted their price target on shares of Danaher from $255.00 to $265.00 and gave the company a “buy” rating in a research report on Wednesday, January 28th. The Goldman Sachs Group lowered their target price on shares of Danaher from $270.00 to $265.00 and set a “buy” rating on the stock in a research note on Thursday, January 29th. JPMorgan Chase & Co. lifted their target price on shares of Danaher from $270.00 to $275.00 and gave the stock an “overweight” rating in a report on Thursday, January 29th. TD Cowen reissued a “buy” rating on shares of Danaher in a research report on Wednesday, January 7th. Finally, Evercore reaffirmed an “outperform” rating and issued a $254.00 price target on shares of Danaher in a research report on Wednesday, January 28th. Nineteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $253.55.

Get Our Latest Analysis on DHR

Danaher Stock Up 0.6%

Shares of DHR opened at $187.34 on Friday. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.51 and a current ratio of 1.87. The company has a 50-day simple moving average of $218.79 and a 200-day simple moving average of $215.34. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $242.80. The firm has a market capitalization of $132.47 billion, a P/E ratio of 37.17, a P/E/G ratio of 2.52 and a beta of 0.93.

Danaher (NYSE:DHRGet Free Report) last released its earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share for the quarter, topping analysts’ consensus estimates of $2.14 by $0.09. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The business had revenue of $6.84 billion for the quarter, compared to the consensus estimate of $6.79 billion. During the same period last year, the business earned $2.14 earnings per share. The firm’s revenue for the quarter was up 4.6% compared to the same quarter last year. On average, equities research analysts expect that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Friday, March 27th will be issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Friday, March 27th. This is a boost from Danaher’s previous quarterly dividend of $0.32. Danaher’s payout ratio is 25.40%.

Insider Activity

In other news, EVP Gregory M. Milosevich sold 1,320 shares of the business’s stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $208.01, for a total transaction of $274,573.20. Following the sale, the executive vice president directly owned 5,099 shares in the company, valued at approximately $1,060,642.99. The trade was a 20.56% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 11.10% of the company’s stock.

About Danaher

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

See Also

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.